Enhancer profiling of breast tumors reveals that chromatin regulatory elements contribute to the clonal fitness landscape, treatment resistance and phenotypic divergence.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cancer Genome Atlas Network. Nature 490, 61–70 (2012).
Curtis, C. et al. Nature 486, 346–352 (2012).
Patten, D. K. Nat. Med. https://doi.org/10.1038/s41591-018-0091-x (2018).
Pogrebniak, K. L. & Curtis, C. Trends Genet. 34, 639–651 (2018).
Dulken, B. W., Leeman, D. S., Boutet, S. C., Hebestreit, K. & Brunet, A. Cell Reports 18, 777–790 (2017).
Chen, H. et al. Cell 173, 386–399.e12 (2018).
Yates, L. R. et al. Nat. Med. 21, 751–759 (2015).
Weintraub, A. S. et al. Cell 171, 1573–1588 (2017).
He, Y. et al. Neuron 55, 217–230 (2007).
Osborne, C. K. & Schiff, R. Annu. Rev. Med. 62, 233–247 (2011).
Azizi, E. et al. Cell https://doi.org/10.1016/j.cell.2018.05.060 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Probert, C., Curtis, C. A role for chromatin regulatory dynamics in breast cancer evolution. Nat Med 24, 1309–1311 (2018). https://doi.org/10.1038/s41591-018-0182-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-018-0182-8